Literature DB >> 20972248

Quantification of the methylation at the GNAS locus identifies subtypes of sporadic pseudohypoparathyroidism type Ib.

Stéphanie Maupetit-Méhouas1, Virginie Mariot, Christelle Reynès, Guylène Bertrand, Francois Feillet, Jean-Claude Carel, Dominique Simon, Hélène Bihan, Vincent Gajdos, Eve Devouge, Savitha Shenoy, Placide Agbo-Kpati, Anne Ronan, Catherine Naud-Saudreau, Anne Lienhardt, Caroline Silve, Agnès Linglart.   

Abstract

BACKGROUND: Pseudohypoparathyroidism type Ib (PHP-Ib) is due to epigenetic changes at the imprinted GNAS locus, including loss of methylation at the A/B differentially methylated region (DMR) and sometimes at the XL and AS DMRs and gain of methylation at the NESP DMR.
OBJECTIVE: To investigate if quantitative measurement of the methylation at the GNAS DMRs identifies subtypes of PHP-Ib. DESIGN AND METHODS: In 19 patients with PHP-Ib and 7 controls, methylation was characterised at the four GNAS DMRs through combined bisulfite restriction analysis and quantified through cytosine specific real-time PCR in blood lymphocyte DNA.
RESULTS: A principal component analysis using the per cent of methylation at seven cytosines of the GNAS locus provided three clusters of subjects (controls n=7, autosomal dominant PHP-Ib with loss of methylation restricted to the A/B DMR n=3, and sporadic PHP-Ib with broad GNAS methylation changes n=16) that matched perfectly the combined bisulfite restriction analysis classification. Furthermore, three sub-clusters of patients with sporadic PHP-Ib, that displayed different patterns of methylation, were identified: incomplete changes at all DMRs compatible with somatic mosaicism (n=5), profound epigenetic changes at all DMRs (n=8), and unmodified methylation at XL in contrast with the other DMRs (n=3). Interestingly, parathyroid hormone concentration at the time of diagnosis correlated with the per cent of methylation at the A/B DMR.
CONCLUSION: Quantitative assessment of the methylation in blood lymphocyte DNA is of clinical relevance, allows the diagnosis of PHP-Ib, and identifies subtypes of PHP-Ib. These epigenetic findings suggest mosaicism at least in some patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20972248     DOI: 10.1136/jmg.2010.081356

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  24 in total

1.  Analysis of Multiple Families With Single Individuals Affected by Pseudohypoparathyroidism Type Ib (PHP1B) Reveals Only One Novel Maternally Inherited GNAS Deletion.

Authors:  Rieko Takatani; Angelo Molinaro; Giedre Grigelioniene; Olta Tafaj; Tomoyuki Watanabe; Monica Reyes; Amita Sharma; Vibha Singhal; F Lucy Raymond; Agnès Linglart; Harald Jüppner
Journal:  J Bone Miner Res       Date:  2015-11-14       Impact factor: 6.741

2.  A novel deletion involving GNAS exon 1 causes PHP1A and further refines the region required for normal methylation at exon A/B.

Authors:  Monica Reyes; Anara Karaca; Murat Bastepe; Nese Ersoz Gulcelik; Harald Jüppner
Journal:  Bone       Date:  2017-07-12       Impact factor: 4.398

3.  Clinical utility gene card for: pseudohypoparathyroidism.

Authors:  Giovanna Mantovani; Agnes Linglart; Intza Garin; Caroline Silve; Francesca M Elli; Guiomar Perez de Nanclares
Journal:  Eur J Hum Genet       Date:  2012-09-12       Impact factor: 4.246

4.  A Homozygous [Cys25]PTH(1-84) Mutation That Impairs PTH/PTHrP Receptor Activation Defines a Novel Form of Hypoparathyroidism.

Authors:  Sihoon Lee; Michael Mannstadt; Jun Guo; Seul Min Kim; Hyon-Seung Yi; Ashok Khatri; Thomas Dean; Makoto Okazaki; Thomas J Gardella; Harald Jüppner
Journal:  J Bone Miner Res       Date:  2015-06-08       Impact factor: 6.741

5.  Pseudohypoparathyroidism type 1B caused by methylation changes at the GNAS complex locus.

Authors:  Sabrina Poradosu; Bert Bravenboer; Rieko Takatani; Harald Jüppner
Journal:  BMJ Case Rep       Date:  2016-05-11

Review 6.  Pseudohypoparathyroidism: one gene, several syndromes.

Authors:  O Tafaj; H Jüppner
Journal:  J Endocrinol Invest       Date:  2016-12-19       Impact factor: 4.256

7.  High frequency of paternal iso or heterodisomy at chromosome 20 associated with sporadic pseudohypoparathyroidism 1B.

Authors:  Cindy Colson; Matthieu Decamp; Nicolas Gruchy; Nadia Coudray; Céline Ballandonne; Claire Bracquemart; Arnaud Molin; Hervé Mittre; Rieko Takatani; Harald Jüppner; Marie-Laure Kottler; Nicolas Richard
Journal:  Bone       Date:  2019-03-21       Impact factor: 4.398

Review 8.  An update on the clinical and molecular characteristics of pseudohypoparathyroidism.

Authors:  Michael A Levine
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-12       Impact factor: 3.243

9.  European guidance for the molecular diagnosis of pseudohypoparathyroidism not caused by point genetic variants at GNAS: an EQA study.

Authors:  Intza Garin; Giovanna Mantovani; Urko Aguirre; Anne Barlier; Bettina Brix; Francesca M Elli; Kathleen Freson; Virginie Grybek; Benedetta Izzi; Agnès Linglart; Guiomar Perez de Nanclares; Caroline Silve; Susanne Thiele; Ralf Werner
Journal:  Eur J Hum Genet       Date:  2014-07-09       Impact factor: 4.246

10.  De novo STX16 deletions: an infrequent cause of pseudohypoparathyroidism type Ib that should be excluded in sporadic cases.

Authors:  Serap Turan; Jaakko Ignatius; Jukka S Moilanen; Outi Kuismin; Helen Stewart; Nicholas P Mann; Agnès Linglart; Murat Bastepe; Harald Jüppner
Journal:  J Clin Endocrinol Metab       Date:  2012-10-18       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.